,西

Wanying Zhang1, Liang Liu2, Qingyan Zhang3,4

  • 1Department of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Nature biotechnology
|July 15, 2025
PubMed
概括

一种新型抗体 - 聚酸结合物有效向耐美西林金黄色葡萄球菌 (MRSA),诱导细菌化以进行根除. 这种方法显示出通过调节免疫反应来治疗抗生素耐药性感染的希望.